MAPS Act

The MAPS Act requires the U.S. Department of Health and Human Services (HHS) to create a database tracking essential medicines and their supply chains, focusing on drugs critical for public health emergencies or shortages. It mandates mapping production locations for key drug ingredients, finished products, and related materials across pharmaceutical manufacturers, with updates to be published by HHS. The bill also requires HHS to submit annual reports to Congress on progress, data gaps, and industry cooperation, while ensuring the database remains confidential and non-public. This primarily affects pharmaceutical manufacturers providing supply chain data and federal agencies coordinating on national security and health security threats.